Senators Ask Medtronic about their Post-Market Device Tracking regarding Infuse

        Senators press Medtronic for device info (Star Tribune) WASHINGTON - Three U.S. senators have asked Fridley-based Medtronic Inc. to supply detailed information about how the company keeps track of its medical devices after they go to market. In a six-page letter that strikes an investigational tone, Sens. Charles Grassley, R-Iowa, Herb Kohl, D-Wis., and Richard Blumenthal, D-Conn., on Thursday called for specific explanations of how Medtronic monitors products once they are released to the public. The letter also seeks specific data about Medtronic's embattled spine product I...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top